Pinnacle Bancorp’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $455K | Buy |
908
+16
| +2% | +$7.68K | 0.12% | 153 |
|
|
2026
Q1 | $438K | Buy |
892
+198
| +29% | +$107K | 0.13% | 142 |
|
|
2025
Q4 | $402K | Buy |
694
+23
| +3% | +$13K | 0.12% | 148 |
|
|
2025
Q3 | $325K | Sell |
671
-121
| -15% | -$56.3K | 0.1% | 167 |
|
|
2025
Q2 | $321K | Hold |
792
| – | – | 0.1% | 170 |
|
|
2025
Q1 | $394K | Sell |
792
-74
| -9% | -$40.1K | 0.13% | 141 |
|
|
2024
Q4 | $451K | Buy |
866
+133
| +18% | +$73.1K | 0.15% | 119 |
|
|
2024
Q3 | $453K | Buy |
733
+29
| +4% | +$17.2K | 0.12% | 118 |
|
|
2024
Q2 | $389K | Hold |
704
| – | – | 0.12% | 122 |
|
|
2024
Q1 | $409K | Sell |
704
-10
| -1% | -$5.61K | 0.12% | 116 |
|
|
2023
Q4 | $379K | Sell |
714
-178
| -20% | -$86.2K | 0.12% | 117 |
|
|
2023
Q3 | $452K | Buy |
892
+200
| +29% | +$107K | 0.16% | 97 |
|
|
2023
Q2 | $361K | Buy |
692
+32
| +5% | +$17.3K | 0.12% | 122 |
|
|
2023
Q1 | $380K | Buy |
660
+41
| +7% | +$23.1K | 0.14% | 116 |
|
|
2022
Q4 | $341K | Hold |
619
| – | – | 0.13% | 121 |
|
|
2022
Q3 | $314K | Sell |
619
-32
| -5% | -$17.9K | 0.14% | 111 |
|
|
2022
Q2 | $354K | Hold |
651
| – | – | 0.15% | 105 |
|
|
2022
Q1 | $385K | Hold |
651
| – | – | 0.13% | 103 |
|
|
2021
Q4 | $434K | Sell |
651
-25
| -4% | -$15.6K | 0.15% | 98 |
|
|
2021
Q3 | $386K | Sell |
676
-24
| -3% | -$13.2K | 0.15% | 104 |
|
|
2021
Q2 | $353K | Sell |
700
-55
| -7% | -$26K | 0.16% | 107 |
|
|
2021
Q1 | $345K | Buy |
755
+99
| +15% | +$47.3K | 0.17% | 108 |
|
|
2020
Q4 | $306K | Buy |
656
+17
| +3% | +$7.97K | 0.19% | 110 |
|
|
2020
Q3 | $282K | Hold |
639
| – | – | 0.2% | 108 |
|
|
2020
Q2 | $232K | Hold |
639
| – | – | 0.17% | 118 |
|
|
2020
Q1 | $181K | Buy |
639
+120
| +23% | +$37.8K | 0.15% | 129 |
|
|
2019
Q4 | $169K | Sell |
519
-14
| -3% | -$4.25K | 0.12% | 151 |
|
|
2019
Q3 | $155K | Buy |
533
+14
| +3% | +$4.01K | 0.09% | 152 |
|
|
2019
Q2 | $152K | Hold |
519
| – | – | 0.09% | 157 |
|
|
2019
Q1 | $142K | Sell |
519
-75
| -13% | -$18.7K | 0.08% | 169 |
|
|
2018
Q4 | $133K | Buy |
+594
| New | +$139K | 0.08% | 164 |
|
|
2017
Q1 | $84K | Buy |
+547
| New | +$83.6K | 0.06% | 214 |
|
Other funds holding TMO
Pinnacle Bancorp's TMO Position: Q2 2026 in Review
Pinnacle Bancorp increased its Thermo Fisher Scientific (TMO) stake by 1.8% in Q2 2026, buying an estimated $7.68K and bringing the position to 908 shares worth $455K. The position accounts for 0.12% of the portfolio, ranked #153.
Pinnacle Bancorp first reported a position in TMO in Q1 2017 and has held it in 32 quarters since. 2,620 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Pinnacle Bancorp held 908 shares of Thermo Fisher Scientific worth $455K as of Q2 2026.
- Pinnacle Bancorp bought 16 Thermo Fisher Scientific shares in Q2 2026, an estimated $7.68K.
- Thermo Fisher Scientific made up 0.12% of Pinnacle Bancorp's portfolio in Q2 2026, its #153 holding.
- Pinnacle Bancorp first reported a position in Thermo Fisher Scientific in Q1 2017 and has held it in 32 quarters since.
- 2,620 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Pinnacle Bancorp's 13F filing for Q2 2026, filed 28 Jul 2026.